|
CCNA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.265200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.367400E-01 |
| Normal-vs-Stage2 |
5.173500E-02 |
| Normal-vs-Stage3 |
4.002600E-01 |
| Normal-vs-Stage4 |
7.955600E-01 |
| Stage1-vs-Stage2 |
2.222200E-04 |
| Stage1-vs-Stage3 |
5.233400E-01 |
| Stage1-vs-Stage4 |
5.121400E-01 |
| Stage2-vs-Stage3 |
1.369850E-02 |
| Stage2-vs-Stage4 |
1.720960E-03 |
| Stage3-vs-Stage4 |
3.107000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.440200E-01 |
| Normal-vs-AfricanAmerican |
4.324800E-01 |
| Normal-vs-Asian |
6.541800E-01 |
| Caucasian-vs-AfricanAmerican |
7.030000E-01 |
| Caucasian-vs-Asian |
8.160800E-01 |
| AfricanAmerican-vs-Asian |
5.758800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.790000E-01 |
| Normal-vs-Female |
3.823600E-01 |
| Male-vs-Female |
3.785400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.767000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.205840E-01 |
| Normal-vs-Age(61-80Yrs) |
4.499600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.670000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.69950000000241E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.700200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.673750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.108300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.192100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.170840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.416400E-01 |
| Classical-VS-Follicular |
1.84740999999988E-05 |
| Classical-VS-Other |
4.351600E-01 |
| Classical-VS-Normal |
6.400800E-01 |
| Tall-VS-Follicular |
2.331600E-02 |
| Tall-VS-Other |
4.230000E-01 |
| Tall-VS-Normal |
8.287800E-01 |
| Follicular-VS-Other |
3.178400E-01 |
| Follicular-VS-Normal |
5.900300E-02 |
| Other-VS-Normal |
3.928400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.597000E-01 |
| Normal-vs-N1 |
4.117400E-01 |
| N0-vs-N1 |
4.777200E-01 |
|
|
